BMS-681
Product Specifications
CAS Number
2760844-13-9
Target
Others
Related Pathways
Others
Bioactivity
BMS-681 is an orthosteric antagonist of chemokine receptor 2 (CCR2) that forms a ternary complex with CCR2 and its allosteric antagonist, CCR2-RA-[R]. Together, the complex inhibits chemokine binding with BVMS-681 in the orthosteric pocket and CCR2-RA-[R] in the intracellular allosteric G-protein binding site. When chemokine binding is inhibited, modulation responses implicated in several inflammatory and neurodegenerative diseases, including atherosclerosis, multiple sclerosis, asthma, neuropathic pain, diabetic nephropathy, and cancer can be controlled. This action occurs as the migration of monocytes, immature dendritic cells, and T-cell subpopulations towards endogenous CC chemokine ligands is mediated.
Smiles
N(C=1C2=C(C=CC(C(F)(F)F)=C2)N=CN1)[C@@H]3C(=O)N(CC3)[C@H]4[C@@H](CCC)C[C@@H](N(C(C)C)C)CC4
Molecular Formula
C26H36F3N5O
Molecular Weight
491.59
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2931050-01 20 µg
Recombinant Cyanothece sp. Cytochrome b6-f complex subunit 4 (petD)
Sign In for Pricing
View Details orb2931050-02 100 µg
Recombinant Cyanothece sp. Cytochrome b6-f complex subunit 4 (petD)
Sign In for Pricing
View Details 
01109 00125 125 mL
EDTA DiSodium Salt 5% Solution for Haematology Staining
Sign In for Pricing
View Details ENZ-ABS677B-0100 100 µg
LAG-3 (human) recombinant monoclonal antibody (L4-PL33) (biotin conjugate)
Sign In for Pricing
View Details